e-learning
resources
Virtual 2021
06.09.2021
Epidemiological aspects of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants
E. Dementyeva (Moscow, Russian Federation), V. Aksenova (Moscow, Russian Federation), A. Kazakov (Moscow, Russian Federation), N. Klevno (Moscow, Russian Federation)
Source:
Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Session:
Epidemiological aspects of tuberculosis
Session type:
E-poster
Number:
2285
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Dementyeva (Moscow, Russian Federation), V. Aksenova (Moscow, Russian Federation), A. Kazakov (Moscow, Russian Federation), N. Klevno (Moscow, Russian Federation). Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants. 2285
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Screening and monitoring of TB infection in rheumatological patients on biologics therapy
Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis
Year: 2021
Efficiency of treatment regimens for chronic tuberculosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 519s
Year: 2003
Screening and monitoring of tuberculosis in patients on biologics treatment
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012
Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis
Source: Eur Respir J 2006; 28: Suppl. 50, 128s
Year: 2006
Design of tuberculosis treatment regimens for drug-resistant and intolerant patients – patient and clinician perspectives
Source: International Congress 2018 – CC4 Tuberculosis
Year: 2018
Clinical efficacy of new anti-TB drug ²tubelon² during complex chemotherapy in patients with first-time diagnosed destuctive pulmonary TB
Source: Eur Respir J 2006; 28: Suppl. 50, 8s
Year: 2006
Corticosteroids as adjunctive therapy in tuberculosis pneumonia with ART
Source: Breathe 2008; 5: 274
Year: 2009
Use of molecular-genetic methods in diagnostics and therapy of a tuberculosis (TB) at patients with HIV
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010
Which patients with COPD can potentially benefit from prophylactic use of antibiotics?
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Appreciation efficiency of standard and alternative antituberculosis preventive therapy in children from different tuberculosis infection sources
Source: Eur Respir J 2006; 28: Suppl. 50, 28s
Year: 2006
Comparison of compliance of two therapeutic regimens in treatment of latent tuberculosis infection in Belgrade children
Source: Eur Respir J 2004; 24: Suppl. 48, 648s
Year: 2004
The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002
Experience of isofon use for therapy and chemoprophylaxis of tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 486s
Year: 2004
Treatment outcomes of new cases of polyresistant pulmonary TB with second line anti-TB drugs in DOTS-Plus regimen
Source: Eur Respir J 2002; 20: Suppl. 38, 359s
Year: 2002
Factors affecting the efficacy of treatment of MDR/XDR TB patients receiving bedaquiline
Source: International Congress 2019 – Tuberculosis: a public health approach
Year: 2019
The pharmacotherapy options for the intensive treatment phase in patients with primarily diagnosed pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Tuberculosis screening in patients receiving biological therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept